Cision PR Newswire

OCI Announces EGM Approval and Updated Indicative Timetable for Orascom Construction Combination

AMSTERDAM, Oct. 31, 2026 /PRNewswire/ -- OCI N.V. ("OCI" or the "Company") (Euronext: OCI) today announced that its shareholders have approved all resolutions relating to the proposed business combination between OCI and Orascom Construction PLC ("Orascom Construction") (the "Combination"). OCI also provides shareholders with an updated indicative timetable for...

QNET’s Bernhard H. Mayer® Brings Emerging Design Talent Into Swiss Watchmaking

Egyptian student wins inaugural Open Innovation Challenge with VELORA, a watch concept set for...

OCI Announces EGM Approval and Updated Indicative Timetable for Orascom Construction Combination

AMSTERDAM, Oct. 31, 2026 /PRNewswire/ -- OCI N.V. ("OCI" or the "Company") (Euronext: OCI)...

Medicilon Presents Revolution Medicines with the “Excellence in Client Partnership Award”

BOSTON, , Oct. 31, 2026 /PRNewswire/ -- Dr. Yang Liu, Director of Medicinal Chemistry at Revolution...

Ericsson announces changes to the Executive Team and to the Market Area structure

Per Narvinger, currently Head of Business Area Cloud Software and Services, is appointed Executive Vice President and new Head of Business...

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA, Spain, Feb. 25, 2025 /PRNewswire/ -- IIIF150, the imaginative ultra-thin rugged phone manufacture, announced their new flagship Raptor 5G which will be showcased...

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management...

DXC tapped by Skanska to Modernize Global IT Infrastructure

ASHBURN, VA, Feb. 25, 2025 /PRNewswire/ -- DXC Technology, (NYSE: DXC), a leading Fortune 500 global technology services provider, has signed an agreement with...

India’s Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

New agreement spans packet core, signaling, charging & policy solutions STOCKHOLM, Feb. 25, 2025 /PRNewswire/ -- India's Bharti...

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint...